293780.KS · 압타바이오
South Korea · RS rating 80 · As of 2026-10-14
| Price | 6,800.00 KRW |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 74 / 92 / 49 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 37 / 31 / 50 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +117.5% |
| Sales growth Q/Q | +67.4% |
| Distance from 52-week high | +34.7% |
| Market cap (USD) | $166.1M |